Lc-Film Protect 4.85 % Solution is a Health Canada–registered veterinary drug (DIN 02440962) held by Liberchem Inc., containing Glycerine. Health Canada lists its status as Cancelled Post Market (status date 30 Jun 2023). Nexara Health has matched 391 registrations of Glycerine across 27 other regulated markets.

Health Canada registration

Glycerine registered in other markets

391 registrations of the same molecule in 27 national registries outside Canada (first 114 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Glycerine worldwide →

Regulator price references for Glycerine

Published list or reimbursement prices for Glycerine presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Lc-Film Protect (DIN 02440962) marketed in Canada?

No. Health Canada lists DIN 02440962 as Cancelled Post Market as of 30 Jun 2023.

Who holds the Canadian licence for this product?

Liberchem Inc. is the company of record in the Health Canada Drug Product Database.

Is Glycerine registered outside Canada?

Yes — Nexara Health has matched 391 registrations in 27 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02440962, status date 2023-06-30; national medicine registries: ANMDMR nomenclator, CBZ, CMED, CNOPS liste des medicaments, CSG Compendio (formulary), DH Drug Office, EDE, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, TLV periodens varor; price sources: CMED, CNOPS liste des medicaments, Lyfjastofnun lyfjaverdskra, MoPH, NHRA, PBS, SFDA, TLV periodens varor. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02440962, status date 2023-06-30; national medicine registries: ANMDMR nomenclator, CBZ, CMED, CNOPS liste des medicaments, CSG Compendio (formulary), DH Drug Office, EDE, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, TLV periodens varor; price sources: CMED, CNOPS liste des medicaments, Lyfjastofnun lyfjaverdskra, MoPH, NHRA, PBS, SFDA, TLV periodens varor.

Health Canada Drug Product Database (DPD), DIN 02440962, status date 2023-06-30; national medicine registries: ANMDMR nomenclator, CBZ, CMED, CNOPS liste des medicaments, CSG Compendio (formulary), DH Drug Office, EDE, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, TLV periodens varor; price sources: CMED, CNOPS liste des medicaments, Lyfjastofnun lyfjaverdskra, MoPH, NHRA, PBS, SFDA, TLV periodens varor. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.